The Oligonucleotides for Cardiovascular and Metabolic Disease Summit is dedicated to the biological and clinical challenges of cardiovascular and metabolic disease related to oligonucleotide drug development.
Topics
- Designing successful clinical trials with appropriate dosage and administration strategies
- Viable targets in vascular, cardiac, and adipose tissue
- Next Generation Non-Coding Targets in Cardiometabolic Disease
- Validating Oligonucleotide Drug Target
- Dosing, Delivery, & Cellular Uptake Minimizing Off-Target Effect & Maximizing Oligonucleotide Delivery to Specific Tissues
- Translational Case Studies to De-risk & Optimize Clinical Trial Development
- Considerations for Rare & Broader Cardiometabolic Indications Balancing Efficacy with Ease-of-Use for Broader Popula
Who should Attend
Attendees from the pharma, biotech and health care industries.
